Functionally, T cell-mediated cancer cell-killing assays and subcutaneous and orthotopic models demonstrated that PRDM1 overexpression in HCC cells dampens T cell-induced cytotoxicity by upregulating tumoral PD-L1 expression. Here, PRDM1 is linked to cancer.